Ovarian follicular development is dependent on the actions and interactions of the pituitary gonadotropins, FSH and LH, and the ovarian steroid hormone, estradiol. Agents which might block the effects of these hormones would increase follicular atresia and reduce fertility. In addition, any substance toxic to the oocyte and its normal pattern of growth and meiosis would lead to reduced numbers of oocytes and follicles and impaired fertility. Autoimmune diseases may be one major cause of premature ovarian failure, and such diseases might be triggered by toxic external stimuli.
The ovarian follicle consists of three cell types: the germ cell (or oocyte), granulosa cells and thecal endocrine cells. The growth, maturation and differentiation of each cell type is required for successful ovulation of a fertilizable ovum and formation of a corpus luteum. Implantation of a fertilized egg subsequently requires the maintenance of a functional corpus luteum.
Interruption of the events leading to follicular ovulation and luteinization or successful maturation of oocytes can occur at many stages. The hypothalamic-hypophyseal-gonadal feedback system itself selects only a few follicles for ovulation. For example, the human ovary contains approximately two million eggs at birth. However, during the reproductively active years of women only 480 eggs ever ovulate (1) . In fact, 80% of the oocytes and follicles contained in the ovary at birth have been lost (degenerate) before the first ovulation ever occurs! With so many follicles degenerating or becoming atretic and so few being selected, it is important to know how this stringent biological selection process works and which steps might be most sensitive to toxic external stimuli.
Three major processes which occur during the life span of a follicle, and which might be susceptible to toxic substances include: mitosis of oogonia and granulosa cells occurring at specific stages of follicular growth; meiosis of oogonia to form oocytes; and differentiation of granulosa cells and theca cells permitting them to respond to the LH surge and ovulate. These three processes occur during the life cycle of a follicle as described below (Fig. 1 
Initiation of Follicle Growth
Initiation of follicular growth occurs continuously until menopause. That is, each day from birth to menopause a certain number of follicles begin to grow. Growth initiation is characterized by three events: the oocyte begins to enlarge; the granulosa cells change from their flattened form to a rounded configuration; and the complex protein/carbohydrate extracellular matrix between the granulosa cells and oocytes, called the zona pellucida, appears. This first stage of growth typifies the class of follicles known as primary follicles. The hornones or factors which trigger the initiation of growth of any given follicle on a given day are as yet unknown. The pituitary hormones, FSH and LH, appear not to be involved in this first step. For lack of a better explanation, some biologists have said this process occurs by chance. However, as more is learned about the biology and molecular biology of development in other systems, the secret to this first step of follicular growth may be unveiled. When this secret is uncovered, it should be possible to inhibit or speed up this process for the specific needs of fertility control.
Follicular Growth
Growth of the ovarian follicle is associated with five events: the oocyte continues to grow; the number of layers of granulosa cells increases; the basal lamina, an extracellular matrix external to the outer layer of granulosa cells is formed; the endocrine thecal cells organize around the basal lamina; and the fluid filled cavity, called an antrum, appears.
The multiple layers of granulosa cells within the follicle are formed by the progressive increase in the number of granulosa cells within the follicle. The most elegant demonstration of their remarkable rate of cell division has been provided by the studies and photographs of Hirshfield (3) . This mitotic activity is maintained throughout follicular growth and ceases only when either luteinization or atresia occurs.
Agents which inhibit cell division would inhibit granulosa cell growth and cause an increase in follicular atresia. Because the growth of the ovarian follicle during this time is dependent on FSH and LH, any agent blocking either the synthesis or action of the gonadotropins would cause an increase in atresia and a decrease in fertility. Some (5) .
To summarize the results of many experiments we can say that the tonic secretion of FSH and LH maintains the growth of follicles to the small antral stage and a subtle increase in LH (or increased responsiveness to LH) is required for the final stages of follicular growth. The increase in LH stimulates the conversion of progesterone to androstenedione by the 17a-hydroxylase/C17-20 lyase enzyme in theca cells. The androgens are then converted to estradiol in granulosa cells. Estradiol acting with FSH (or cAMP) is obligatory for regulating the differentiation of granulosa cells including the increased cellular content of LH receptors, FSH receptors, aromatase activity, cholesterol side chain cleavage, cytochrome P-450 (P-450CSCC) and prostaglandin synthetase (5, 6) . The last of these regulates the synthesis of prostaglandins which are increased by the LH surge and are then obligatory for ovulation to occur.
The essence of this brief overview is that the differentiation of theca cells (increased androgen synthesis) determines which follicles will gain the substrates necessary for estradiol synthesis. Only those follicles capable of producing estradiol become preovulatory follicles ( Fig. 2) pling of the receptor to adenylate cyclase will also cause atresia and lowered fertility. Premature ovarian failure can also be linked to the immune system. For example, fetal thymectomy in monkeys (7) and mice (8, 9) leads to abnormal ovarian differentiation in adult animals. Exposure of animals to the glycoprotein components of the zona pellucida leads to the synthesis of antibodies and the dramatic loss of oocytes from the ovary (10). Thus, premature menopause could be linked to an autoimmune disease in which antibodies to the zona pellucida or other structures of the follicle could result in the loss of follicles.
Atresia as it occurs naturally is a poorly understood process but plays a key role in fertility (11) . Atresia may result from gonadotropin concentrations which are too low or may be stimulated by an endogenous antagonist. As more and more peptides within the ovary are characterized it is possible that a specific atretogenic factor will be identified.
In summary, external agents may interfere with fertility at the ovarian level by acting at many sites to: (1) decrease the concentrations of gonadotropins, (2) destroy oocytes, (3) cause autoimmune mechanisms to operate, (4) increase antigonadal peptides, (5) inhibit the actions of LH and FSH (cAMP), (6) inhibit the action of estradiol, (7) prevent luteinization, (8) increase synthesis luteolytic factors, and (9) alter gene transcription and prevent differentiation.
The tools to measure many of the functional aspects of granulosa and theca cell differentiation (such as hormone receptors) are now available. Recombinant DNA technology is also going to provide new and sensitive tools with which to identify how various agents alter ovarian cell function (12) (13) (14) (15) . These tools, applied to the toxicology of the ovary, could provide important new insight into the control of follicular and luteal cell function.
